| The rise of CRISPR/Cas for genome editing in stem cells B Shui, L Hernandez Matias, Y Guo, Y Peng Stem cells international 2016 (1), 8140168, 2016 | 41 | 2016 |
| Inducible and reversible inhibition of miRNA-mediated gene repression in vivo G La Rocca, B King, B Shui, X Li, M Zhang, KM Akat, P Ogrodowski, ... Elife 10, e70948, 2021 | 28 | 2021 |
| Systematically assessing microbiome–disease associations identifies drivers of inconsistency in metagenomic research BT Tierney, Y Tan, Z Yang, B Shui, MJ Walker, BM Kent, AD Kostic, ... PLoS biology 20 (3), e3001556, 2022 | 21 | 2022 |
| Interplay between K-RAS and miRNAs B Shui, G La Rocca, A Ventura, KM Haigis Trends in cancer 8 (5), 384-396, 2022 | 11 | 2022 |
| Allosteric regulation of switch-II domain controls KRAS oncogenicity MH Yang, TH Tran, B Hunt, R Agnor, CW Johnson, B Shui, TJ Waybright, ... Cancer research 83 (19), 3176-3183, 2023 | 4 | 2023 |
| Oncogenic K-Ras suppresses global miRNA function B Shui, TS Beyett, Z Chen, X Li, G La Rocca, WM Gazlay, MJ Eck, KS Lau, ... Molecular Cell 83 (14), 2509-2523. e13, 2023 | 3 | 2023 |
| Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammation L Suarez-Lopez, B Shui, DK Brubaker, M Hill, A Bergendorf, ... Iscience 24 (12), 2021 | 1 | 2021 |
| MicroRNA-Mediated Response to Pathophysiological Stress in the Intestine B Shui Harvard University, 2023 | | 2023 |
